D. Hasan, “Diagnostic impact of CEA and CA 15-3 on monitoring chemotherapy of breast cancer patients: Chemotherapy monitoring by serum markers”, J Circ Biomark, vol. 11, no. 1, pp. 57–63, Nov. 2022.